Gri Bio Inc (GRI)

Jan 07, 2026

What Wall Street predicts for GRI Bio Inc. stock priceBullish Engulfing Patterns & Small Entry Portfolio - ulpravda.ru

Jan 07, 2026

Jan 05, 2026

What drives GRI Bio Inc stock priceEarnings Forecast Updates & High Yield Trading Growth - earlytimes.in

Jan 05, 2026

Jan 03, 2026

Decliners Report: Is GRI Bio Inc stock attractive for hedge funds2025 Bull vs Bear & Free Community Consensus Stock Picks - moha.gov.vn

Jan 03, 2026

Dec 30, 2025

12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga

Dec 30, 2025

Dec 29, 2025

GRI Bio approves reverse stock split, stockholders vote in favor - MSN

Dec 29, 2025

Dec 26, 2025

12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga

Dec 26, 2025

Dec 22, 2025

GRI Bio Inc. (GRI) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Dec 22, 2025

Dec 21, 2025

What technical signals suggest for GRI Bio Inc. stockEarnings Growth Report & Safe Entry Point Identification - Улправда

Dec 21, 2025

Dec 20, 2025

What insider trading reveals about GRI Bio Inc. stockLong Setup & Real-Time Buy Zone Alerts - Улправда

Dec 20, 2025

Dec 20, 2025

Why GRI Bio Inc. stock remains on buy listsWeekly Trade Analysis & Weekly Setup with High ROI Potential - Улправда

Dec 20, 2025

Dec 19, 2025

Why GRI Bio Inc. stock could be next big winnerJuly 2025 Intraday Action & Expert Approved Momentum Ideas - DonanımHaber

Dec 19, 2025

Dec 19, 2025

What sentiment indicators say about GRI Bio Inc. stockWeekly Market Outlook & Weekly Momentum Stock Picks - Улправда

Dec 19, 2025

Dec 17, 2025

Oral therapy GRI-0621 boosts lung function, repairs tissue in IPF: Data - Pulmonary Fibrosis News

Dec 17, 2025

Dec 16, 2025

GRI Bio announces GRI-0621-IPF-02 trial met primary, secondary endpoints - MSN

Dec 16, 2025

Dec 13, 2025

GRI Bio Closes $8 Million Public Offering - The Globe and Mail

Dec 13, 2025

Dec 12, 2025

GRI Bio closes $8 million public offering of common stock and warrants - Investing.com Nigeria

Dec 12, 2025

Dec 12, 2025

GRI Bio closes $8 million public offering of common stock and warrants By Investing.com - Investing.com South Africa

Dec 12, 2025

Dec 12, 2025

GRI Bio (Nasdaq: GRI) details closing of offering, equity over $2.5M post-transaction - Stock Titan

Dec 12, 2025

Dec 12, 2025

GRI Bio Announces Closing of $8.0 Million Public Offering - GlobeNewswire

Dec 12, 2025

Dec 12, 2025

GRI Bio Launches $6.7 Million Public Offering - TipRanks

Dec 12, 2025

Dec 12, 2025

GRI Bio (NASDAQ: GRI) details $6.7M equity deal and runway into Q4 2026 - Stock Titan

Dec 12, 2025

Dec 11, 2025

GRI Bio prices $8 million public offering at $0.75 per share - Investing.com

Dec 11, 2025

Dec 11, 2025

GRI Bio announces pricing of $8M public offering - MSN

Dec 11, 2025

Dec 11, 2025

GRI Bio’s IPF drug shows positive Phase 2a results with improved lung function - Investing.com India

Dec 11, 2025

Dec 11, 2025

12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga

Dec 11, 2025

Dec 11, 2025

GRI Bio Announces Pricing of $8,000,000 Million Public Offering - The Manila Times

Dec 11, 2025

Dec 11, 2025

GRI Bio (NASDAQ: GRI) prices $8,000,000 offering of 10,666,667 shares at $0.75 - Stock Titan

Dec 11, 2025

Dec 11, 2025

What's Going On With GRI Bio Stock Thursday?GRI Bio (NASDAQ:GRI) - Benzinga

Dec 11, 2025

Dec 11, 2025

GRI Bio’s tazarotene achieves Phase IIa IPF success - Yahoo

Dec 11, 2025

Dec 11, 2025

GRI Bio Meets Key Goals In Phase 2 Trial Of GRI-0621 For Idiopathic Pulmonary Fibrosis - Nasdaq

Dec 11, 2025

Dec 10, 2025

GRI Bio announces positive Phase 2a trial results - MSN

Dec 10, 2025

Dec 10, 2025

GRI Bio Announces Positive Phase 2a Trial Results - TipRanks

Dec 10, 2025

Dec 10, 2025

GRI Bio, Inc. Announces Positive Phase 2a Trial Results for GRI-0621 - TradingView

Dec 10, 2025

Dec 10, 2025

GRI Bio Announces Positive Topline Data from its Phase 2a Study in Idiopathic Pulmonary Fibrosis (“IPF”) - GlobeNewswire

Dec 10, 2025

Dec 09, 2025

A new trading data show Milestone Pharmaceuticals Inc (MIST) is showing positive returns. - Setenews

Dec 09, 2025

Dec 09, 2025

GRI Bio (NASDAQ: GRI) updates Form S-1 with extensive warrant and contract exhibits - Stock Titan

Dec 09, 2025

Dec 09, 2025

Financial Contrast: CalciMedica (NASDAQ:CALC) and GRI Bio (NASDAQ:GRI) - Defense World

Dec 09, 2025

Dec 08, 2025

U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.45% - Investing.com UK

Dec 08, 2025

Dec 08, 2025

U.S. stocks lower at close of trade; Dow Jones Industrial Average down 0.45% - Investing.com

Dec 08, 2025

Dec 08, 2025

12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga

Dec 08, 2025

Dec 08, 2025

GRI Bio Reports Positive Phase 2a Trial Results - TipRanks

Dec 08, 2025

Dec 08, 2025

GRI Bio Increceives topline data from phase 2a trial for idiopathic pulmonary fibrosisSEC filing - marketscreener.com

Dec 08, 2025

Dec 08, 2025

GRI Bio Reports Positive Phase 2a Trial Results for IPF Treatment - TradingView

Dec 08, 2025

Dec 08, 2025

GRI Bio (NASDAQ: GRI) reports Phase 2a IPF topline results for GRI-0621 - Stock Titan

Dec 08, 2025

Dec 08, 2025

Ascendiant Capital Maintains GRI Bio (GRI) Buy Recommendation - Nasdaq

Dec 08, 2025

Dec 08, 2025

Ascendiant Capital Raises Price Target for GRI to $36.00 | GRI S - GuruFocus

Dec 08, 2025

Dec 05, 2025

Why GRI Bio Inc. stock is seen as undervaluedSell Signal & Weekly Return Optimization Alerts - Newser

Dec 05, 2025

Dec 03, 2025

JTC Team Companies to Present in Webull Corporate Connect Webinar Series: Biotech/MedTech on August 19-21, 2025 - The Herald-Mail

Dec 03, 2025

Dec 02, 2025

GRI Bio receives Nasdaq notice for non-compliance with equity listing rule - Investing.com Australia

Dec 02, 2025

Dec 01, 2025

GRI Bio (GRI) Stock Analysis Report | Financials & Insights - Benzinga

Dec 01, 2025

Nov 28, 2025

Stop Loss: What sentiment indicators say about GRI Bio Inc. stock2025 Retail Activity & Long-Term Growth Portfolio Plans - moha.gov.vn

Nov 28, 2025